We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Dips More Than Broader Market: What You Should Know
Read MoreHide Full Article
Albemarle (ALB - Free Report) ended the recent trading session at $98.51, demonstrating a -2.73% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.06%. Meanwhile, the Dow gained 0.38%, and the Nasdaq, a tech-heavy index, lost 0.44%.
The specialty chemicals company's stock has dropped by 13.83% in the past month, falling short of the Basic Materials sector's loss of 7.88% and the S&P 500's gain of 2.36%.
The upcoming earnings release of Albemarle will be of great interest to investors. The company's earnings report is expected on November 4, 2026. The company is predicted to post an EPS of $2.44, indicating a 1384.21% growth compared to the equivalent quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $1.49 billion, up 14.15% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of $11.25 per share and a revenue of $6.08 billion, demonstrating changes of +1524.05% and +18.18%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 1.27% downward. Albemarle currently has a Zacks Rank of #5 (Strong Sell).
Investors should also note Albemarle's current valuation metrics, including its Forward P/E ratio of 9.01. This signifies a discount in comparison to the average Forward P/E of 15.34 for its industry.
Investors should also note that ALB has a PEG ratio of 0.6 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. By the end of yesterday's trading, the Chemical - Diversified industry had an average PEG ratio of 1.18.
The Chemical - Diversified industry is part of the Basic Materials sector. With its current Zacks Industry Rank of 206, this industry ranks in the bottom 17% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.
View the Zacks #1 Rank List
Image: Bigstock
Albemarle (ALB) Dips More Than Broader Market: What You Should Know
Albemarle (ALB - Free Report) ended the recent trading session at $98.51, demonstrating a -2.73% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.06%. Meanwhile, the Dow gained 0.38%, and the Nasdaq, a tech-heavy index, lost 0.44%.
The specialty chemicals company's stock has dropped by 13.83% in the past month, falling short of the Basic Materials sector's loss of 7.88% and the S&P 500's gain of 2.36%.
The upcoming earnings release of Albemarle will be of great interest to investors. The company's earnings report is expected on November 4, 2026. The company is predicted to post an EPS of $2.44, indicating a 1384.21% growth compared to the equivalent quarter last year. Meanwhile, our latest consensus estimate is calling for revenue of $1.49 billion, up 14.15% from the prior-year quarter.
For the full year, the Zacks Consensus Estimates project earnings of $11.25 per share and a revenue of $6.08 billion, demonstrating changes of +1524.05% and +18.18%, respectively, from the preceding year.
Additionally, investors should keep an eye on any recent revisions to analyst forecasts for Albemarle. These revisions typically reflect the latest short-term business trends, which can change frequently. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 1.27% downward. Albemarle currently has a Zacks Rank of #5 (Strong Sell).
Investors should also note Albemarle's current valuation metrics, including its Forward P/E ratio of 9.01. This signifies a discount in comparison to the average Forward P/E of 15.34 for its industry.
Investors should also note that ALB has a PEG ratio of 0.6 right now. The PEG ratio bears resemblance to the frequently used P/E ratio, but this parameter also includes the company's expected earnings growth trajectory. By the end of yesterday's trading, the Chemical - Diversified industry had an average PEG ratio of 1.18.
The Chemical - Diversified industry is part of the Basic Materials sector. With its current Zacks Industry Rank of 206, this industry ranks in the bottom 17% of all industries, numbering over 250.
The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.